Junwan Wu

机构：Sun Yat-sen University, Qi2, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China

发表论文 8 篇 · 总被引 48 次 · h-index 4

代表论文

• Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer (2023 · International Journal of Biological Sciences · 被引 23)
• Natural Killer Cell Activation Signature Identifies Cyclin B1/CDK1 as a Druggable Target to Overcome Natural Killer Cell Dysfunction and Tumor Invasiveness in Melanoma (2025 · Pharmaceuticals · 被引 6)
• Addition of anti‐PD‐1 immunotherapy to BRAF inhibitor‐based targeted therapy improves real‐world survival and delays brain metastases in patients with BRAF V600 ‐mutant advanced melanoma: a multicenter cohort study (2025 · MedComm · 被引 5)
• A Single-Inductor Triple-Output Buck-Boost Converter with Output Ripple Control for Wearable Devices (2022 · 被引 5)
• Comprehensive pan‐cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance (2024 · Clinical and Translational Medicine · 被引 4)
• Quality changes of clinical practice guidelines for respiratory diseases in China: A systematic review (2021 · The Clinical Respiratory Journal · 被引 2)